Eric Patzer is Director of Aridis Pharmaceuticals, Inc.. Currently has a direct ownership of 884,600 shares of ARDS, which is worth approximately $0. The most recent transaction as insider was on Jun 24, 2024, when has been sold 714,286 shares (Common stock purchase) at a price of $0.07 per share, resulting in proceeds of $50,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 885K
0% 3M change
23.87% 12M change
Total Value Held $0

Eric Patzer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
BUY
Open market or private purchase
$50,000 $0.07 p/Share
714,286 Added 44.67%
884,600 Common stock purchase
Jun 05 2023
BUY
Exercise of conversion of derivative security
-
12,000 Added 1.65%
714,132 Common Stock
Jul 27 2021
BUY
Open market or private purchase
$25,047 $4.84 p/Share
5,175 Added 0.73%
702,132 Common Stock
Dec 22 2020
SELL
Bona fide gift
-
16,000 Reduced 2.24%
696,957 Common Stock
EP

Eric Patzer

Director
Los Gatos, CA

Track Institutional and Insider Activities on ARDS

Follow Aridis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARDS shares.

Notify only if

Insider Trading

Get notified when an Aridis Pharmaceuticals, Inc. insider buys or sells ARDS shares.

Notify only if

News

Receive news related to Aridis Pharmaceuticals, Inc.

Track Activities on ARDS